Thorell Marella
- SEC CIK
- 0001826323
No open-market purchases or sales filed in the past year.
Current role at each company
- MCRB Seres Therapeutics, Inc.See Remarksas of Jul 10, 2026
- EPIX ESSA Pharma Inc.Directoras of Oct 15, 2025
- CARM Carisma Therapeutics Inc.Directoras of Jul 1, 2024
- EVLO Evelo Biosciences, Inc.Chief Financial Officeras of Nov 8, 2023
- GRI GRI Bio, Inc.Directoras of Dec 15, 2022
Show 1 more company
- CNTA Centessa Pharmaceuticals plcChief Accounting Officeras of Mar 23, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Thorell Marella as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EVLO Evelo Biosciences, Inc.
Chief Financial Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2023 (view filing)8:31 PM ET | Nov 8 | Same day | Thorell MarellaChief Financial Officer | SSale | −1.81K | $0.33 | −$597.63 | −7.5%22.3K after | 10b5-1 |
| Nov 3, 2023 (view filing)4:11 PM ET | Nov 2 | 1 day | Thorell MarellaChief Financial Officer | SSale | −4.00K | $0.33 | −$1.32K | −18.5%17.6K after | 10b5-1 |
| Aug 9, 2023 (view filing) | Aug 8 | 1 day | Thorell MarellaChief Financial Officer | SSale | −2.00K | $9.51 | −$19.1K | −18.1%9.07K after | 10b5-1 |
| May 10, 2023 (view filing)9:31 PM ET | May 8 | 2 days | Thorell MarellaChief Financial Officer | SSale | −38.5K | $0.1255 | −$4.84K | −29.6%91.5K after | 10b5-1 |